MedPath

ICAHN School of Medicine At Mount Sinai

ICAHN School of Medicine At Mount Sinai logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1963-01-01
Employees
5K
Market Cap
-
Website
http://www.mssm.edu

Safety and Efficacy of Cognitive Behavior Therapy for People With Post-traumatic Stress and Cardiovascular Illness

Not Applicable
Completed
Conditions
Stress Disorders, Post-Traumatic
Interventions
Behavioral: Cognitive behavioral therapy (CBT)
Behavioral: Educational session and treatment as usual
First Posted Date
2006-08-16
Last Posted Date
2017-12-26
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
60
Registration Number
NCT00364910
Locations
🇺🇸

Elmhurst Hospital Center, Queens, New York, United States

🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Guanfacine to Treat Borderline Personality Disorder

Not Applicable
Conditions
Borderline Personality Disorder
First Posted Date
2006-08-01
Last Posted Date
2006-08-01
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Registration Number
NCT00358969
Locations
🇺🇸

Mount Sinai Hospital - Mood & Personality Research Group, New York, New York, United States

Pharmacology of Cognition in Schizotypal Personality Disorder

Phase 4
Terminated
Conditions
Schizotypal Personality Disorder
Personality Disorders
Interventions
Drug: Placebo
First Posted Date
2006-07-18
Last Posted Date
2017-02-10
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
29
Registration Number
NCT00353379
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Omega-3 Fatty Acids in Adolescent Depression

Phase 2
Completed
Conditions
Adolescent Depression
Interventions
First Posted Date
2006-04-11
Last Posted Date
2018-04-19
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
57
Registration Number
NCT00312897
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Manhattan HIV/Hepatology Brain Bank

Completed
Conditions
Hepatitis
HIV
First Posted Date
2006-03-08
Last Posted Date
2016-03-17
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
187
Registration Number
NCT00300209
Locations
🇺🇸

Mount Sinai School of Medicine, New York, New York, United States

Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults

Not Applicable
Completed
Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
Behavioral: Meta-Cognitive Therapy
Behavioral: Supportive Therapy
First Posted Date
2006-01-18
Last Posted Date
2017-04-04
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
88
Registration Number
NCT00278473
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Topiramate in the Treatment of Pathological Gambling

Phase 3
Terminated
Conditions
Pathological Gambling
Interventions
Drug: Placebo
First Posted Date
2005-10-28
Last Posted Date
2019-07-02
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
42
Registration Number
NCT00245583
Locations
🇺🇸

Mount Sinai School of Medicine, New York, New York, United States

Patient Centered Randomized Controlled Trial

Not Applicable
Completed
Conditions
Early-Stage Breast Cancer
Interventions
Behavioral: Patient Assistance
Behavioral: Information only
First Posted Date
2005-10-05
Last Posted Date
2013-12-03
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
374
Registration Number
NCT00233077
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

🇺🇸

Metropolitan Hospital, New York, New York, United States

🇺🇸

Queens Hospital Center, Queens, New York, United States

and more 5 locations

Treatment of Post-Traumatic Brain Injury (TBI) Depression

Phase 2
Completed
Conditions
Depression
Interventions
Drug: Placebo
First Posted Date
2005-10-05
Last Posted Date
2015-11-13
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
52
Registration Number
NCT00233103
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Post-Traumatic Brain Injury (Post-TBI) Fatigue and Its Treatment

Phase 2
Terminated
Conditions
Fatigue
Interventions
Drug: Placebo
First Posted Date
2005-10-05
Last Posted Date
2016-04-15
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
21
Registration Number
NCT00233090
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath